Thanks to the breakthroughs of mRNA technology in creating COVID-19 vaccines, the method is being put to the test for other diseases that have plagued humanity for millennia. And the fast rollout necessitated by a global pandemic has compressed 10 or 15 years of progress into a brief period. Developers at Moderna, Pfizer, and BioNTech are optimistic they can create effective vaccines for cardiovascular, autoimmune, and several respiratory diseases and individual cancers. They might even be able to develop vaccines for diseases that have so far resisted treatment.
CANCER VACCINES
The nature of mRNA-based vaccines makes them more effective than previous vaccines because they teach human cells to make proteins they don’t naturally make. In the case of a potential mRNA cancer vaccine, that means immune systems could recognize proteins on cancer cells and then attack those cells while leaving healthy ones alone.
“We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives,” Moderna chief medical officer Dr. Paul Burton told the Guardian. “I think we will be able to offer personalized cancer vaccines against multiple different tumor types to people around the world.”
この記事は The BOSS Magazine の June 2023 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は The BOSS Magazine の June 2023 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Travel Well in 2025
The best places to see & best things to do in the new year
Getting Back to giving
How to revive charitable donations, with Charitybuzz CEO Ben Erwin
Breathtaking BUILDINGS
THE WORLD'S MOST AWE-INSPIRING EDIFICES
ALong for the Ride
Clean energy projects go up in areas once dominated by fossil fuels
HEALTHCARE ANALYTICS: FIGHTING THE GOOD FIGHT
Advanced analytics are transforming healthcare operations and patient care. Nevada's Renown Health is leading the way, creating a roadmap for swift and effective change.
THE RIGHT ACCELERANT
THE POSSIBILITIES - AND LIMITATIONS OF AI IN SCIENTIFIC RESEARCH
IN GLOBAL LOGISTICS
How thinking global and acting local is enlarging the global footprint of the Staci Group
THE RIGHT STUFF
Why veterans thrive in logistics
LIVING MACHINES
BIOHYBRIDS BRING THE POWER OF NATURE TO ROBOTICS
MANUFACTURING'S NEW LOOK
The industry’s reputation doesn’t match reality, but the future is bright